United States of America
Francois Nader, M.D., has been a director of Alexion since November 2017. Dr. Nader served as President, Chief Executive Officer, and Executive Director of NPS Pharma, a global biotechnology company that was focused on delivering innovative therapies to patients with rare diseases, from 2008 to 2015. Prior to NPS, Dr. Nader was a venture partner at Care Capital, a venture capital firm. He previously served on the North America Leadership Team of Aventis Pharma and its predecessor companies, holding a number of executive positions in integrated healthcare markets and medical and regulatory affairs. He also led global commercial operations at the Pasteur Vaccines division of Rhone-Poulenc. Dr. Nader currently serves as non-executive chairman of Acceleron Pharma, Inc. and on the boards of Advanced Accelerator Applications, Clementia Pharmaceuticals Inc., and private company ArRETT Neuroscience.
Pharma and Pharmaceutical Science